Literature DB >> 15728488

Generation of antigen-specific, Foxp3-expressing CD4+ regulatory T cells by inhibition of APC proteosome function.

Yingzi Cong1, Astrid Konrad, Nuzhat Iqbal, Robin D Hatton, Casey T Weaver, Charles O Elson.   

Abstract

We tested the hypothesis that immature APC, whose NF-kappaB-signaling pathway and thus maturation was blocked by the proteosome inhibitor benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal (PSI), could be a source of Ag-specific regulatory T (Treg) cells. DO11.10 CD4(+) T cells that were incubated with Ag- and PSI-pulsed APC proliferated poorly, produced less IL-2, IFN-gamma, and IL-10 in secondary cultures, and inhibited the response of both naive and memory CD4(+) T cells stimulated by Ag-pulsed APC. The generation of PSI-APC Treg cells required IL-10 production by APC. PSI-APC Treg cell inhibition required cell-cell contact but not IL-10 or TGF-beta. Addition of IL-2 did not reverse, but Ab to CTLA-4 did reverse partially the inhibitory effect. Depletion of CD25(+) T cells before initial culture with PSI-APC did not affect Treg generation. PSI-APC Treg cells expressed high levels of Foxp3, inhibited proliferation of naive DO11.10 T cells in vivo, and abrogated colitis driven by a memory Th1 response to bacterial-associated Ag. We conclude that NF-kappaB-blocked, immature APC are able to induce the differentiation of Treg cells that can function in vitro and in vivo in an Ag-specific manner.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728488     DOI: 10.4049/jimmunol.174.5.2787

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Influence of dietary components on regulatory T cells.

Authors:  Shohreh Issazadeh-Navikas; Roman Teimer; Robert Bockermann
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

2.  T regulatory cell suppression of colitis: the role of TGF-beta.

Authors:  R Duchmann; M Zeitz
Journal:  Gut       Date:  2006-05       Impact factor: 23.059

Review 3.  Advancements in immune tolerance.

Authors:  Ping-Ying Pan; Junko Ozao; Zuping Zhou; Shu-Hsia Chen
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

4.  Apoptotic cell administration enhances pancreatic islet engraftment by induction of regulatory T cells and tolerogenic dendritic cells.

Authors:  Cong Wu; Yi Zhang; Yingming Jiang; Quanxing Wang; Yao Long; Chunmei Wang; Xuetao Cao; Guoyou Chen
Journal:  Cell Mol Immunol       Date:  2013-07-22       Impact factor: 11.530

5.  Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production.

Authors:  Ting Feng; Hongwei Qin; Lanfang Wang; Etty N Benveniste; Charles O Elson; Yingzi Cong
Journal:  J Immunol       Date:  2011-04-29       Impact factor: 5.422

6.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

7.  Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD.

Authors:  Pascal Meier; Dela Golshayan; Edouard Blanc; Manuel Pascual; Michel Burnier
Journal:  J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 10.121

Review 8.  The gut microbiota shapes intestinal immune responses during health and disease.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

9.  Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells.

Authors:  James F George; Andrea Braun; Todd M Brusko; Reny Joseph; Subhashini Bolisetty; Clive H Wasserfall; Mark A Atkinson; Anupam Agarwal; Matthias H Kapturczak
Journal:  Am J Pathol       Date:  2008-05-29       Impact factor: 4.307

10.  T cells stimulated in vitro have a suppressive function but do not contain only regulatory T cells.

Authors:  E Valencic; E Piscianz; A Tommasini; M Granzotto
Journal:  Clin Exp Immunol       Date:  2007-09-27       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.